Clinical Trials

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02264210 2024-09-25

CORIN

128 enrolled 9 charts

Phase 2 Active not recruiting

Adenocarcinoma of Lung, Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05007938 2024-08-23

Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT05514314 2022-08-24

A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection

90 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02044328 2022-02-08

ICAPE

79 enrolled

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT05132985 2021-12-10

Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05104788 2021-11-03

NeoIpower

Phase 2 Recruiting

27 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03736837 2021-03-15

ALTER-L004

60 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT02726568 2019-02-19

High Dose Icotinib With Sequential SRS For NSCLC Patients Harboring EGFR Mutation With Brain Metastases

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03754530 2018-11-27

Icotinib Combined With Radiation Therapy For NSCLC Patients With Brain Metastases and EGFR Mutation

162 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03396185 2018-07-18

Icotinib as Consolidation Therapy After Chemoradiotherapy in EGFR-Mutant Stage IIIA-IIIB Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT03123484 2017-04-21

β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02960607 2016-11-18

High-dose Icotinib Treatment Beyond Progression in EGFR Mutant NSCLC

25 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02961270 2016-11-11

Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation

Carcinoma, Non-Small-Cell Lung

NCT02738983 2016-04-14

RT Plus EGFR-TKI for Wild-type NSCLC

22 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01707329 2015-09-09

Icotinib in Combination With Chemotherapy Versus Chemotherapy Alone in Patients Progressed After Icotinib Treatment

180 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01843647 2015-07-15

Neoadjuvant Therapy of Icotinib in Epidermal Growth Factor Receptor Mutated NSCLC Patients

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02062515 2015-07-15

Icotinib in Advanced Non-small Cell Lung Cancer (NSCLC) With Hepatic Insufficiency

Carcinoma, Non-Small-Cell Lung

NCT01929200 2015-05-22

Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation

120 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02027090 2015-05-22

High Dose Versus Routine Dose Icotinib in Advanced Non-small Cell Lung Cancer Patients With Stable Disease

64 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02430974 2015-04-30

Chemotherapy of NSCLC With or Without Icotinib

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02407366 2015-04-02

Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02191059 2014-07-31

Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01514877 2014-07-23

Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

20 enrolled

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT01688713 2012-09-20

Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer

20 enrolled